PACS Group, Inc. (PACS) is a small-cap value stock trading at $14.13 with strong fundamentals. The company manages 316 facilities with over 32,000 skilled nursing beds and 2,400 assisted living beds, serving nearly 30,000 patients daily. Despite SEC filing delays, PACS has secured NYSE extensions through November 19, 2025, indicating regulatory confidence in its value.

PACS Group, Inc. has resolved technical defaults with lenders and strengthened its leadership team. The company’s cash balances increased to $294 million, providing ample liquidity for operations and growth. With its stock trading near $12, significantly below analyst targets of $30+, PACS presents a high-upside opportunity for equity investors with potential for re-rating to $20–30 per share.

A bullish thesis on PACS Group, Inc. highlights its strong operational metrics and structural demand. The stock, trading near $12, remains significantly undervalued compared to its peers. With filings expected to be cleared imminently, PACS presents a high-upside opportunity for equity investors with potential for re-rating to $20–30 per share or more as regulatory and market uncertainties are resolved.

Read more at Yahoo Finance: PACS Group, Inc. (PACS): A Bull Case Theory